Class IIOngoingD-0353-2021
Drug recall · May 5, 2021
PremierZen Platinum 5000 recall
Why: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006
- Lots / codes
Lot #: GATCO 01671, Exp Date 12/30/2024 Serial # 728175421856
- Quantity
- N/A
- Company
- Na Na Collection, Elmwood Park, NJ
- Distribution
- Nationwide with the United States
- Initiated
- March 30, 2021 · Voluntary: Firm initiated
- Classified
- April 26, 2021
- Reported
- May 5, 2021
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.